Alice Oliffson Kamphorst

17PUBLICATIONS
177CO-AUTHORS
Tumour immunologyPredictive and prognostic markersInnate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 01, 2026
B cells sustain tumor-specific CD4 T cells to promote response to PD-1 targeted therapy.

|Jul 16, 2026
Dendritic cells control tertiary lymphoid structure development and maintenance in cancer.

|Jan 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo

|Nov 18, 2025
Guidelines for T cell nomenclature.

David Masopust, Amit Awasthi, Rémy Bosselut

|Sep 15, 2025
Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy.

Ruben Fernandez-Rodriguez, Sara Cuadrado-Castano, Andrew Edwards

|Nov 19, 2024
NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma.

Katherine E Lindblad, Romain Donne, Ian Liebling

Pageof 3

Frequent Collaborators

7 joint publications

Etienne Humblin

6 joint publications

Verena van der Heide

5 joint publications

Abishek Vaidya

4 joint publications

Miriam Merad